What Is a Cosmetic Product Information File (PIF)? EU & UK Requirements Explained
“A PIF is regulatory documentation, but most of what goes into it starts much earlier with the formula, raw materials, testing, claims and manufacturing decisions.”
If you're developing a cosmetic product for the European Union or Great Britain, you will eventually encounter three regulatory acronyms that are easy to blur together:
PIF. CPSR. CPNP.
They are related, but they are not interchangeable.
A Product Information File (PIF) is the maintained regulatory file containing key information about a cosmetic product, including its safety report, manufacturing information, and, where applicable, evidence supporting its claimed effects.
A Cosmetic Product Safety Report (CPSR) is the safety assessment contained within the PIF.
And for the EU, CPNP is the electronic notification system used to notify cosmetic products before they are placed on the market. Great Britain has its own notification system, the SCPN.
For founders, the bigger lesson is that international cosmetic compliance isn't something added to the product after formulation.
The documentation ultimately traces back to decisions made while the product is being developed.
What Is a Cosmetic Product Information File?
A Cosmetic Product Information File, usually called a PIF, is the regulatory dossier that the Responsible Person must maintain for a cosmetic product placed on the EU market.
Article 11 of Regulation (EC) No 1223/2009 requires the PIF to contain five main categories of information:
A description of the cosmetic product
The Cosmetic Product Safety Report
A description of the manufacturing method and a statement of compliance with Good Manufacturing Practice
Proof of the claimed effect, where justified by the nature or effect of the product
Data on animal testing performed by the manufacturer, its agents, or suppliers relating to development or safety assessment, including certain testing performed to satisfy requirements of third countries
Great Britain retains a closely related PIF framework under its cosmetics regime. Current UK government guidance similarly requires the Responsible Person to maintain an up-to-date PIF for cosmetic products placed on the GB market.
This makes the PIF much more than a folder containing an ingredient list.
It is part of the documented regulatory history of the finished product.
Is a PIF Required for Every Cosmetic Product?
For cosmetic products placed on the European Union market, the Responsible Person must keep a PIF for the product.
The same general requirement applies in Great Britain under the applicable GB cosmetics framework.
This applies to cosmetic products, not simply products a brand happens to describe as beauty products.
Product classification matters.
A moisturizer, shampoo, lipstick, body lotion, facial serum, cleanser, or other conventional cosmetic may fall within cosmetics regulation.
A product making therapeutic claims or performing another regulated function may fall into a different regulatory category.
That classification question should be addressed early because the regulatory path can change substantially depending on what the product is and what the brand intends to claim.
Who Is Responsible for the PIF?
This is where founders need to understand the concept of the Responsible Person.
Under EU cosmetics law, a cosmetic product placed on the market must have a designated Responsible Person within the applicable jurisdiction. The Responsible Person carries regulatory responsibilities for the product, including maintaining the PIF.
Great Britain similarly requires a Responsible Person for cosmetics made available to consumers there. Current UK guidance states that the Responsible Person must keep the PIF up to date and ensure the product complies with the applicable regulatory requirements.
The Responsible Person may, depending on the circumstances and jurisdiction, be connected to the manufacturer, importer, distributor, brand, or an appointed third-party Responsible Person service.
For a U.S. founder entering Europe, this is an important structural difference from simply manufacturing a product domestically and shipping orders internationally.
Someone must occupy the legally defined Responsible Person role.
A PIF and a CPSR Are Not the Same Thing
This is probably the most common source of confusion.
The PIF is the broader product file.
The CPSR is one component of that file.
Under the EU Cosmetics Regulation, the Cosmetic Product Safety Report is required under Article 10 and is incorporated into the PIF under Article 11.
Think of the relationship this way:
PIF = complete regulatory product file
CPSR = cosmetic safety report inside the PIF
The CPSR itself contains detailed information used to evaluate whether the cosmetic product is safe for its intended and reasonably foreseeable use.
What Is Included in a Cosmetic Product Safety Report?
The CPSR has two broad parts.
Part A: Cosmetic Product Safety Information
This provides the technical information needed to perform the safety assessment.
Current UK government guidance, which reflects the underlying cosmetics framework, identifies information including:
Quantitative and qualitative composition
Physical and chemical characteristics of ingredients and the finished product
Stability
Microbiological quality
Information concerning preservation
Impurities and traces
Packaging material
Normal and reasonably foreseeable use
Exposure to the cosmetic product
Exposure to individual substances
Toxicological profiles
Undesirable and serious undesirable effects
Other relevant information about the product
This is where formulation decisions become regulatory information.
The safety assessor isn't evaluating the front label's list of hero ingredients.
They need to understand the actual product.
Part B: Cosmetic Product Safety Assessment
Part B contains the safety assessor's professional conclusion.
It addresses areas including:
The safety assessment conclusion
Required warnings or instructions for use
Scientific reasoning supporting the conclusion
The safety assessor's credentials and approval of the assessment
This assessment must be completed by an appropriately qualified safety assessor.
In Great Britain, current government guidance describes the appropriate qualification as a university-level qualification in pharmacy, toxicology, medicine, or a similar discipline, or a recognized equivalent.
This is why a cosmetic chemist developing the formula and the qualified professional signing the CPSR may be different people.
Their roles overlap technically, but they are not the same regulatory function.
The Quantitative Formula Matters
A consumer ingredient list is not enough to complete a meaningful cosmetic safety assessment.
The safety assessor needs the quantitative composition of the product.
That means the actual concentration of ingredients in the formulation, along with the technical information necessary to evaluate exposure and safety.
For a founder, this creates a practical reason to understand formula ownership before international expansion.
If your manufacturer owns the formula and you do not have access to its quantitative composition, you may need the manufacturer to provide the necessary confidential information through an acceptable process to the appropriate regulatory parties.
That doesn't automatically prevent compliance.
But it can reduce how much control the brand has over its own regulatory workflow.
Formula Ownership and Regulatory Documentation Are Different
Owning your formula does not make your product compliant.
And having a compliant PIF does not necessarily mean you own your formula.
These are separate issues.
A private-label manufacturer may retain ownership of a formula while supplying confidential quantitative information appropriately for regulatory assessment.
A custom-formulated brand may own its complete quantitative formula but still need a qualified safety assessor, Responsible Person, appropriate testing, manufacturing documentation, notification, and all other applicable regulatory steps.
The strategic advantage of 100% formula ownership is control.
When a brand owns its quantitative formula, it can know and control:
Which ingredients are present
Their percentages
Which commercial raw materials are specified
Which active forms are used
Which materials may need to change for another market
How future reformulations affect the product
That can make international product evolution easier to manage.
It does not replace regulatory compliance.
What Formula Information Does the Safety Assessor Actually Need?
This is where an INCI list stops being sufficient.
Suppose the label lists:
Aqua, Glycerin, Niacinamide, Squalane, Ceramide NP...
That tells the safety assessor what ingredients appear in the finished declaration.
It doesn't necessarily tell them enough about the actual materials used.
Commercial cosmetic raw materials can themselves be blends.
A ceramide complex, botanical extract, preservative blend, peptide solution, emulsifier, fragrance, or active delivery system may contain multiple components.
The safety assessment may therefore require supporting information beyond what the consumer sees on the package.
Depending on the material and assessment, that can involve:
Raw-material composition
Active concentration
Supplier specifications
Safety documentation
Impurities
Restricted substances
Fragrance documentation
Technical information relevant to exposure or safety
This is one reason organized raw-material documentation becomes increasingly important as a product moves toward international commercialization.
Why Raw-Material Documentation Matters
Founders tend to focus on the formula.
Regulatory teams also care about what the formula is made from.
The same consumer-facing ingredient can be supplied in very different commercial forms.
A botanical extract might arrive in:
Water
Glycerin
Propanediol
Alcohol
Oil
It may also contain preservatives or other supporting ingredients.
A peptide marketed under one trade name may actually be supplied as a solution containing the peptide plus water, humectants, preservatives, or other components.
The ingredient declaration eventually reflects the appropriate INCI composition, but the safety assessment needs sufficient information to understand the material being evaluated.
This is why choosing raw materials from technically organized suppliers can make commercialization easier later.
The cheapest sample isn't always the cheapest ingredient once documentation becomes part of the equation.
What Manufacturing Information Goes Into the PIF?
Article 11 requires the PIF to include a description of the method of manufacture and a statement of compliance with Good Manufacturing Practice.
That does not mean the PIF needs to become a public manufacturing manual.
The objective is to document that the product is being produced appropriately and that the relevant GMP requirements are addressed.
For brands working with contract manufacturers, this is another reason regulatory planning and manufacturing selection should be connected.
A beautiful formula developed in a laboratory is only one part of the commercial product.
The way it is manufactured matters too.
Does the PIF Need Stability Testing?
Stability information forms part of the safety information considered in the CPSR. UK government guidance specifically identifies the physical and chemical characteristics and stability of the cosmetic product among the information needed for Part A.
This is an important distinction:
The PIF doesn't create product stability.
The formulation and packaging need to be designed and evaluated for stability during development.
The resulting evidence then supports the regulatory documentation.
That is why I prefer to think of stability as something built into the product from day one rather than a regulatory box checked at the end.
Ingredient selection, preservation, pH, packaging, oxidation risk, processing, and product architecture can all affect what happens over time.
What About Microbiological Testing and Challenge Testing?
Microbiological quality and preservation are also relevant to the safety assessment.
For products susceptible to microbial contamination, the safety documentation may need information supporting the effectiveness of the preservation system. Current UK guidance specifically includes microbial contamination and how preservatives prevent contamination among the information relevant to CPSR Part A.
The exact testing strategy depends on the product.
A water-based facial cream and a low-water anhydrous balm do not necessarily present the same microbiological risk.
This is why testing strategy should follow the actual formulation rather than a generic checklist.
Cosmeta's guides to Preservative Efficacy Testing vs. Challenge Testing and cosmetic stability testing can provide deeper context on how these development tests fit into commercialization.
Packaging Is Part of the Safety Picture
Packaging isn't merely a design decision.
UK government guidance specifically includes information about what has been used to package the product among the information supporting the cosmetic safety assessment.
That makes sense technically.
The finished product is the formula inside its package.
A package can affect:
Product exposure to air
Light exposure
Consumer contamination
Dispensing
Product protection
Compatibility over time
This is why changing packaging late in development can create more work than founders expect.
The formula may be unchanged.
The finished product system isn't.
Claims Can Become Part of the PIF
Article 11 specifically requires proof of the effect claimed for the cosmetic product where justified by the nature or effect of the product.
This is an important point for marketing teams.
A claim shouldn't exist in isolation from the product evidence.
If a brand wants to communicate measurable performance, it should think about what evidence will support that positioning.
Depending on the claim, support might involve:
Ingredient evidence
Supplier data
Instrumental testing
Consumer perception studies
Clinical testing
Finished-product studies
Other appropriate substantiation
The strength of evidence needed depends on what is being claimed.
A simple cosmetic description and a highly specific quantified efficacy claim are not the same thing.
Ingredient Evidence Is Not Always Finished-Product Evidence
This distinction matters increasingly as beauty brands build marketing around clinical percentages.
Suppose a supplier has excellent research showing its active technology improved a particular skin parameter at a defined use level.
That evidence can be highly useful.
But it does not automatically mean every finished product containing the ingredient can claim the exact same result.
Was the ingredient used at the tested level?
Is it the same commercial material?
Is the finished formulation similar enough for the evidence to be relevant?
Does the claim describe the ingredient or the finished product?
Would finished-product testing be more appropriate?
This is where formulation, claims strategy, and regulatory review intersect.
The marketing team wants the strongest statement.
The technical team needs to know what the evidence actually supports.
Does Every Marketing Claim Need a Clinical Study?
No.
The EU Cosmetics Regulation does not state that every cosmetic claim requires a dedicated clinical trial.
Article 11 requires proof of claimed effects where justified, and claims must be supportable rather than misleading.
The appropriate substantiation depends on the nature and specificity of the claim.
This is another reason claims strategy should begin before the packaging is finalized.
A brand can spend a great deal of time designing around a claim only to discover later that the evidence doesn't support the wording it wants to use.
What About Animal Testing Information?
Animal-testing data is one of the five categories specifically identified in Article 11.
The PIF must include data on animal testing performed by the manufacturer, its agents, or suppliers relating to development or safety assessment of the cosmetic product or its ingredients, including certain testing undertaken to satisfy requirements in third countries.
This requirement should not be confused with permission to conduct cosmetic animal testing freely within the EU.
The EU cosmetics framework contains separate prohibitions concerning animal testing and marketing, while Article 11 establishes what information must be maintained in the PIF.
For founders, the practical point is that the regulatory file has to account for the history and supporting information behind the product, not merely the current ingredient label.
The PIF Is a Living Document
One of the most useful ways to understand the PIF is that it is not simply created once and forgotten.
Current UK regulatory guidance explicitly describes the PIF as a living document that should be updated as necessary.
That matters because products change.
A raw material may be replaced.
New safety information may become available.
A claim may change.
Additional test data may be generated.
The CPSR may need updating.
A formula may be revised.
The regulatory documentation needs to continue reflecting the product actually being sold.
This is where version control becomes important.
A perfect PIF for Formula V2 isn't very useful if the manufacturer is producing Formula V6.
When Does a Formula Change Require a PIF Update?
There isn't a useful universal rule that every formula change can simply be added to the existing PIF.
The significance of the change matters.
Current UK enforcement guidance notes that PIFs should be updated when necessary, such as when new data changes the CPSR. It also states that when a product is significantly different from a same-name product previously placed on the market, updating the existing file may not be sufficient and a new PIF may need to be considered.
That makes change control important.
Switching:
A fragrance
A preservative
An active concentration
A raw-material grade
A packaging system
A manufacturing process
can have different regulatory implications depending on what changed and why.
The correct response isn't automatically “new PIF” or “no problem.”
The change needs to be evaluated.
How Long Must a PIF Be Kept?
Under the current EU Cosmetics Regulation, the PIF must be retained for 10 years after the date on which the last batch of the cosmetic product was placed on the market.
Great Britain's current framework likewise requires a ten-year retention period after the last batch was placed on the market.
This means documentation responsibilities can continue long after a brand stops actively manufacturing a product.
Discontinuing the SKU does not mean deleting the regulatory file.
Where Is the PIF Kept?
Under EU law, the Responsible Person must make the PIF readily accessible, electronically or in another format, to the competent authority at the address indicated on the product label. The information must be available in a language that can be easily understood by the competent authority where the PIF is kept.
This is another reason the Responsible Person's address appearing on the label isn't just packaging fine print.
It is tied to regulatory accountability.
Great Britain similarly requires the PIF to be maintained by the Responsible Person and accessible under the applicable UK framework.
Is the PIF Submitted to the Government?
Generally, don't think of the PIF as a document you routinely upload in full during product notification.
The PIF must be maintained and made readily accessible to the competent authority.
That is different from notification.
For the European Union, the product is notified electronically through the Cosmetic Products Notification Portal, or CPNP. The European Commission describes CPNP as the free electronic notification system established under the Cosmetics Regulation.
Great Britain uses the Submit Cosmetic Product Notifications, or SCPN, service. Current UK guidance states that cosmetic products must be notified before being made available to GB consumers.
So:
PIF = maintained product documentation
CPSR = safety report within the PIF
CPNP = EU product notification
SCPN = Great Britain product notification
They are related steps, not different names for the same thing.
PIF vs. CPNP: What Is the Difference?
This distinction deserves its own answer because founders frequently search the terms together.
The PIF contains the detailed regulatory and safety documentation supporting the cosmetic product.
The CPNP is the EU portal through which required product information is notified before the product is placed on the EU market.
The European Commission states that once a product is notified through CPNP, additional national notification is not required within the EU.
Notification does not eliminate the need for the PIF.
The Responsible Person still needs to maintain the underlying product documentation.
What Does a U.S. Beauty Brand Need Before Selling in Europe?
This is where the PIF becomes commercially important for American founders.
A product can be perfectly legitimate for sale in the United States and still not be ready for the EU.
Before European commercialization, a brand needs to consider issues including:
Formula compliance
Ingredient restrictions
Responsible Person requirements
Safety assessment
PIF
Labeling
Claims
Product notification
Manufacturing and GMP
Applicable special requirements, such as those involving certain nanomaterials
The product should therefore be reviewed for the intended market before the brand commits to packaging and large-scale production.
Finding out that a formula needs modification after 50,000 printed cartons have arrived is a very expensive way to learn about international regulatory strategy.
Does the United States Require a PIF?
No. The United States does not use the EU-style Product Information File as its regulatory framework for cosmetics.
But that does not mean U.S. cosmetic companies can ignore product documentation or safety.
Under the Modernization of Cosmetics Regulation Act of 2022, or MoCRA, the Responsible Person must ensure and maintain records supporting adequate substantiation of safety for the cosmetic product. FDA also makes clear that it does not prescribe one universal testing regimen for demonstrating cosmetic safety.
So the regulatory structures differ.
EU/GB: formal PIF framework.
United States: no EU-style PIF, but safety substantiation and other applicable records and obligations still matter.
A U.S. brand should not assume that complying with MoCRA automatically produces everything required for an EU PIF.
Likewise, having an EU PIF does not eliminate separate U.S. obligations.
Can One PIF Cover the EU and Great Britain?
The underlying technical documentation may overlap substantially because Great Britain's cosmetics framework retains many concepts originating from Regulation (EC) No 1223/2009.
But the regulatory systems are no longer identical.
Among the most obvious differences are the Responsible Person and notification structures.
EU products use an appropriate EU Responsible Person and CPNP notification.
Products placed on the Great Britain market operate under the GB Responsible Person framework and SCPN notification.
Brands selling into both markets should therefore manage compliance by jurisdiction rather than assuming that one administrative action covers everything.
Northern Ireland also requires separate consideration because its cosmetics regulatory relationship differs from Great Britain. Current UK government guidance notes that businesses placing cosmetics on the Northern Ireland market use CPNP through a Responsible Person based in Northern Ireland or the EEA.
Build the Documentation While You Build the Product
This is the part of PIF preparation that matters most from a formulation perspective.
Don't wait until the formula is finished and then begin searching old emails for:
The final percentages.
The correct raw-material trade names.
Supplier specifications.
Preservative documentation.
Fragrance information.
Stability results.
Packaging details.
Claims evidence.
Manufacturing information.
The better approach is to create a product-development record as the formula evolves.
Then regulatory documentation becomes an extension of development rather than an archaeological project.
Ingredient Selection Can Make International Compliance Easier or Harder
Not every technically interesting raw material is equally easy to commercialize globally.
A formulator developing for international markets should consider questions such as:
Is the ingredient permitted for the intended cosmetic use?
Are there concentration restrictions?
Does the supplier provide adequate documentation?
Are there relevant impurities?
Does it contain nanomaterials?
Are any supporting ingredients hidden behind a trade name that need to be accounted for?
Is the fragrance documentation available?
Can the material support the intended market and claims?
This doesn't mean the most documented ingredient is automatically the best ingredient.
It means regulatory viability belongs in ingredient selection alongside efficacy, sensory performance, stability, cost, and sourcing.
Your Supplier Choice Can Affect Your Regulatory Workload
Two suppliers may sell materials that sound almost identical on an ingredient list.
One provides a sophisticated documentation package.
The other sends a specification sheet and little else.
Those materials are not necessarily equivalent from a product-development standpoint.
For a brand planning multiple international markets, supplier documentation can become a meaningful selection criterion.
This is one of those formulation decisions consumers will never see.
They may ultimately see the benefit indirectly because the brand can expand into another market without rebuilding the product from scratch.
Certifications and Retailer Standards Are Separate From the PIF
Another common source of confusion is assuming that a regulatory PIF demonstrates compliance with voluntary retailer or certification programs.
It doesn't.
A brand may separately want to meet requirements associated with:
COSMOS
Ecocert
Credo
Sephora Clean
Vegan positioning
Cruelty-free programs
National Eczema Association acceptance
Other retailer, certification, or brand standards
Those programs have their own criteria.
The PIF addresses regulatory obligations for the applicable cosmetics market.
A product can have a complete PIF and still fail a retailer's ingredient standard.
Likewise, meeting a clean retailer standard does not replace regulatory compliance.
This is why product strategy should begin with:
Who is this for, where are we selling it, and which standards actually matter?
Then the formula can be designed around the relevant requirements rather than accumulating exclusions with no commercial purpose.
PIF Preparation Is Easier When the Product Was Developed for the Intended Market
There is a major difference between:
“We want to sell this formula in Europe.”
and:
“We're developing this formula for U.S., EU and UK commercialization.”
The second statement gives the formulation and regulatory teams a chance to account for international requirements from the beginning.
Ingredient selection can consider the intended markets.
Claims can be developed appropriately.
Supplier documentation can be collected.
Testing can be planned.
Packaging can be reviewed.
Manufacturing documentation can be organized.
The result isn't necessarily a different formula.
It's a product developed with fewer regulatory surprises.
What Happens If the Manufacturer Owns the Formula?
Private-label and manufacturer-owned formulas can still be commercialized internationally when the necessary regulatory information is made available through appropriate confidential channels.
Formula ownership is not itself a requirement for obtaining a PIF.
But ownership affects control.
If the manufacturer controls the quantitative formula, the brand may depend on that manufacturer to support safety assessment, regulatory documentation, and future changes.
That can work perfectly well.
The trade-off becomes more noticeable when the brand wants to:
Change manufacturers
Enter additional markets
Adjust an active concentration
Replace a restricted ingredient
Meet a new retailer standard
Change the preservative system
Optimize COGS
Update the product around newer ingredient technology
At that point, control of the quantitative formula becomes more strategically useful.
Why 100% Formula Ownership Can Matter for International Expansion
When a brand owns the complete quantitative formula, it has a clearer view of the product architecture that regulators and safety assessors ultimately need to understand.
It knows the percentages.
It knows the specified raw materials.
It can identify which ingredient is causing an international compliance issue.
It can evaluate an alternative.
It can provide the appropriate confidential information to regulatory professionals.
It can update the formula deliberately.
And, subject to manufacturing validation and third-party intellectual-property rights, it can potentially transfer the product to another qualified manufacturer.
That doesn't make compliance automatic.
It gives the brand greater control over the product while pursuing compliance.
There is an important distinction there.
Your PIF Does Not Replace Formula Ownership
The PIF contains commercially sensitive product information, but having regulatory access to that information does not necessarily give the brand contractual ownership of the formula.
Likewise, ownership of the formula does not give the brand ownership of:
Supplier patents
Trademarked ingredient technologies
Proprietary raw-material compositions
Licensed delivery systems
Third-party intellectual property
These questions are governed by different contracts and legal rights.
For a growing beauty company, it is useful to keep three concepts separate:
Regulatory access
Formula ownership
Third-party intellectual property
They can overlap.
They are not interchangeable.
Who Should Assemble the PIF?
There isn't one universal answer because different professionals may contribute different pieces.
The process can involve:
The Responsible Person
Qualified safety assessor
Regulatory consultant
Brand
Cosmetic chemist
Contract manufacturer
Raw-material suppliers
Testing laboratories
Claims or clinical testing partners
The safety assessor performs the qualified safety assessment.
The manufacturer may supply manufacturing and GMP information.
The chemist may provide formulation and raw-material documentation.
Testing laboratories provide relevant results.
The Responsible Person ultimately carries the applicable responsibility for maintaining the PIF and ensuring compliance.
This is why regulatory readiness is a team activity even though one party has the formal Responsible Person role.
How Much Does a Cosmetic PIF Cost?
There is no universal PIF price because “PIF preparation” can describe very different scopes of work.
Cost can vary based on:
Formula complexity
Number of raw materials
Quality of existing documentation
Safety-assessment requirements
Number of product variants
Claims
Testing already completed
Missing supplier information
Responsible Person services
Markets being entered
Whether reformulation is necessary
A straightforward, well-documented product is much easier to assess than a formula containing dozens of poorly documented raw materials and unsupported claims.
This is another reason regulatory planning during formulation can reduce cost later.
How Long Does PIF Preparation Take?
There isn't a universal timeline either.
If the product is already appropriately formulated, documentation is organized, required testing is complete, supplier information is available, and the safety assessor has everything needed, the regulatory work can move relatively efficiently.
If the process reveals:
Missing documentation
Insufficient stability information
Preservation questions
Formula compliance issues
Unsupported claims
Incomplete manufacturing information
Packaging concerns
then PIF preparation may expose additional work that has to happen first.
The PIF isn't causing the delay.
It's revealing that the product wasn't as commercialization-ready as it appeared.
The PIF Is a Good Test of Product-Development Maturity
A founder may see a finished bottle and think:
The product is done.
A regulatory professional sees something different.
Can we identify exactly what is in it?
Do we have the final quantitative formula?
Do we understand the raw materials?
Is the safety assessment supportable?
Is stability documented?
Is preservation appropriate?
Do we know how it is manufactured?
Can the claims be substantiated?
Is the package part of the assessment?
Can we identify the current commercial version?
Those questions reveal whether the company has developed a commercial product or merely a very good prototype.
That is why regulatory documentation shouldn't be viewed as paperwork sitting downstream from product development.
It is evidence that the product-development process produced something sufficiently defined to commercialize.
Key Takeaways
A Product Information File (PIF) is the regulatory file that must be maintained for cosmetic products placed on markets including the European Union and Great Britain. Under the EU Cosmetics Regulation, it contains the product description, CPSR, manufacturing and GMP information, relevant proof of claimed effects, and required animal-testing information.
The CPSR is part of the PIF, not another name for it.
The CPNP is the EU notification system, while Great Britain uses SCPN. Notification and PIF maintenance are separate obligations.
The PIF must be maintained and updated as necessary. Under both the current EU and GB frameworks, it must generally be retained for ten years after the last batch is placed on the market.
The United States does not use the same PIF framework, although MoCRA requires the Responsible Person to maintain records supporting adequate safety substantiation.
And the easiest PIF to build is generally the one nobody waited until the end to think about.
Cosmeta's Perspective
I think founders sometimes hear regulatory documentation and imagine a separate administrative step that happens after the chemist finishes the product.
In reality, a good PIF tells the story of decisions that started much earlier.
What exactly is in the formula?
Which commercial raw materials were used?
Are those materials appropriately documented?
Is the product stable?
Is it adequately preserved?
Does the packaging make sense?
What are we claiming?
What evidence supports those claims?
How is the product manufactured?
Those aren't filing questions.
They're product-development questions.
And I think this becomes even more important as brands become more international.
You don't necessarily need to make every formula satisfy every market on Earth. That can create its own unnecessary limitations.
But you should know your intended markets early enough that regulatory strategy can influence the product intelligently.
The same is true of formula ownership.
Owning a quantitative formula doesn't replace the Responsible Person, CPSR, PIF, testing, or regulatory review. What it gives the brand is control over the technical asset those processes are evaluating.
For a company that expects its products to evolve, expand internationally, move manufacturers, or adapt to new retailer requirements, that control can become increasingly valuable.
Ready for the Next Step
If international expansion is part of the product roadmap, identify the target markets before the formula is commercially locked. Ingredient selection, supplier documentation, testing, packaging, claims, manufacturing, and regulatory strategy are easier to align during development than after inventory has already been produced.
The goal isn't simply to create a PIF.
It's to develop a product for which the PIF can be built confidently.
FAQs
-
A Product Information File (PIF) is the regulatory file maintained for a cosmetic product placed on markets including the European Union and Great Britain. Under EU law, it contains the product description, Cosmetic Product Safety Report, manufacturing and GMP information, proof of claimed effects where justified, and required information concerning animal testing.
-
The PIF is the complete product information file, while the Cosmetic Product Safety Report (CPSR) is one required component within it. The CPSR contains the information and qualified safety assessment used to establish the safety of the cosmetic product for its intended and reasonably foreseeable use.
-
No. The United States does not use the EU-style PIF framework. However, under MoCRA, the Responsible Person must ensure and maintain records supporting adequate substantiation of the cosmetic product's safety. U.S. brands expanding into the EU or Great Britain must separately address the regulatory requirements of those markets.
-
Under the EU Cosmetics Regulation, the PIF must be retained for 10 years after the date the last batch of the cosmetic product was placed on the market. Great Britain's current cosmetics framework also uses a ten-year retention period.
-
Potentially, yes. A PIF is maintained as a current product record and should be updated when necessary. Changes to the formula, safety information, testing, claims, packaging, or other relevant product information may require corresponding updates to the PIF or CPSR. For a sufficiently significant product change, simply updating the existing PIF may not always be appropriate, and the Responsible Person should evaluate whether a new file is needed.
